Location History:
- Tsukuba, JP (2008 - 2021)
- Tokyo, JP (2003 - 2024)
Company Filing History:
3 out of 237 
3 out of 47 
3 out of 318 
Years Active: 2003-2024
Title: Hiroshi Hirai: Innovator in Antitumor Therapies
Introduction
Hiroshi Hirai is a prominent inventor based in Tsukuba, Japan, known for his significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 10 patents to his name, Hirai has made remarkable strides in cancer treatment methodologies.
Latest Patents
Hirai's latest patents include an innovative antitumor agent and method for tumor therapy. This invention provides an effective method for using an orally administrable compound that selectively inhibits Aurora A, in combination with a microtubule-targeting drug. The method outlines a specific administration schedule that involves a cycle of 7 days, where the microtubule-targeting drug is administered once, and the compound is given for 3 consecutive days, followed by a 4-day cessation. Another notable patent focuses on an antitumor drug for intermittent administration of an FGFR inhibitor. This invention aims to provide a potent and selective FGFR inhibitor while alleviating side effects, such as elevated blood phosphorus concentration, without compromising its antitumor efficacy.
Career Highlights
Throughout his career, Hiroshi Hirai has worked with reputable companies, including Banyu Pharmaceutical Co. Ltd and MSD K.K. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.
Collaborations
H
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.